XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts

Title
XPLN is modulated by HDAC inhibitors and negatively regulates SPARC expression by targeting mTORC2 in human lung fibroblasts
Authors
Keywords
mTORC2, XPLN, SPARC, Idiopathic pulmonary fibrosis, HDAC inhibitor
Journal
PULMONARY PHARMACOLOGY & THERAPEUTICS
Volume 44, Issue -, Pages 61-69
Publisher
Elsevier BV
Online
2017-03-15
DOI
10.1016/j.pupt.2017.03.003

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now